Isoquercetin has been used in trials studying the treatment of Kidney Cancer, Renal cell carcinoma, Advanced Renal Cell Carcinoma, Thromboembolism of Vein in Pancreatic Cancer, and Thromboembolism of Vein VTE in Colorectal Cancer, among others. The directory classifies it as a commercial API with a natural source/manufacturing origin. Other names for this substance include Hirsutrin, 3-Glucosylquercetin, Quercetin-3-glucoside and BRN 0100989. Its PubChem CID is 5280804.
Isoquercetin
| CAS No | 482-35-9 |
|---|---|
| Molecular Formula | C21H20O12 |
| Molecular Weight | 464.38 g/mol |
| Synonyms | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Isoquercetin has been used in trials studying the treatment of Kidney Cancer, Renal cell carcinoma, Advanced Renal Cell Carcinoma, Thromboembolism of Vein in Pancreatic Cancer, and Thromboembolism of Vein VTE in Colorectal Cancer, among others.
The listed CAS number is 482-35-9.
The listed molecular formula is C21H20O12.
The listed molecular weight is 464.38 g/mol.
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one.
The source lists Hirsutrin, 3-Glucosylquercetin, Quercetin-3-glucoside and BRN 0100989.